Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease

Open Webpage

Arash Nazeri, Habib Ganjgahi, Tina Roostaei, Thomas E. Nichols, Mojtaba Zarei

Published: 01 Jan 2014, Last Modified: 20 May 2025NeuroImage 2014EveryoneRevisionsBibTeXCC BY-SA 4.0
Abstract: Highlights•Combining protein levels and MRI is a useful method in identifying biomarkers.•Plasma BNP, IL16, PYY, TBG and APOE proteins can screen 93% of subjects with AD.•Changes of BMP6, Eselectin, MMP10 and NrCAM predict 94% of MCI converted to AD.